Moleculin Biotech Files 8-K with Corporate Updates
Ticker: MBRX · Form: 8-K · Filed: Oct 30, 2025 · CIK: 1659617
Sentiment: neutral
Topics: corporate-disclosure, financial-reporting, exhibits
Related Tickers: MBRX
TL;DR
Moleculin Biotech (MBRX) filed an 8-K on 10/30/25 detailing corporate info & exhibits.
AI Summary
Moleculin Biotech, Inc. filed an 8-K on October 30, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's principal executive offices located at 5300 Memorial Drive, Suite 950, Houston, TX 77007, and its telephone number is (713) 300-5160. The company is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This 8-K filing provides essential corporate information and disclosures for investors and stakeholders of Moleculin Biotech, Inc., including its financial reporting and operational addresses.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks or material adverse events.
Key Numbers
- 001-37758 — SEC File Number (Identifies the company's filing history with the SEC.)
- 47-4671997 — EIN (Employer Identification Number for tax purposes.)
Key Players & Entities
- Moleculin Biotech, Inc. (company) — Registrant
- October 30, 2025 (date) — Date of earliest event reported
- 5300 Memorial Drive, Suite 950, Houston, TX 77007 (address) — Principal executive offices
- 713-300-5160 (phone_number) — Registrant's telephone number
- Delaware (jurisdiction) — State of incorporation
FAQ
What specific items are being disclosed in this 8-K filing?
This 8-K filing specifically reports under 'Regulation FD Disclosure' and 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on October 30, 2025.
What is the primary business address of Moleculin Biotech, Inc.?
The primary business address is 5300 Memorial Drive, Suite 950, Houston, TX 77007.
In which state was Moleculin Biotech, Inc. incorporated?
Moleculin Biotech, Inc. was incorporated in Delaware.
What is the telephone number for Moleculin Biotech, Inc.?
The telephone number for Moleculin Biotech, Inc. is (713) 300-5160.
Filing Stats: 494 words · 2 min read · ~2 pages · Grade level 10.1 · Accepted 2025-10-30 16:57:31
Filing Documents
- mbrx20251030_8k.htm (8-K) — 26KB
- ex_879731.htm (EX-99.1) — 18KB
- a01.jpg (GRAPHIC) — 10KB
- slide01.jpg (GRAPHIC) — 68KB
- slide02.jpg (GRAPHIC) — 61KB
- slide03.jpg (GRAPHIC) — 60KB
- slide04.jpg (GRAPHIC) — 62KB
- slide05.jpg (GRAPHIC) — 80KB
- slide06.jpg (GRAPHIC) — 86KB
- slide07.jpg (GRAPHIC) — 76KB
- slide08.jpg (GRAPHIC) — 42KB
- slide09.jpg (GRAPHIC) — 74KB
- slide10.jpg (GRAPHIC) — 64KB
- slide11.jpg (GRAPHIC) — 53KB
- slide12.jpg (GRAPHIC) — 50KB
- slide13.jpg (GRAPHIC) — 49KB
- slide14.jpg (GRAPHIC) — 65KB
- slide15.jpg (GRAPHIC) — 89KB
- slide16.jpg (GRAPHIC) — 81KB
- slide17.jpg (GRAPHIC) — 67KB
- slide18.jpg (GRAPHIC) — 64KB
- slide19.jpg (GRAPHIC) — 66KB
- slide20.jpg (GRAPHIC) — 68KB
- slide21.jpg (GRAPHIC) — 66KB
- slide22.jpg (GRAPHIC) — 69KB
- slide23.jpg (GRAPHIC) — 53KB
- slide24.jpg (GRAPHIC) — 61KB
- slide25.jpg (GRAPHIC) — 64KB
- slide26.jpg (GRAPHIC) — 61KB
- slide27.jpg (GRAPHIC) — 57KB
- slide28.jpg (GRAPHIC) — 57KB
- slide29.jpg (GRAPHIC) — 36KB
- 0001437749-25-032447.txt ( ) — 2744KB
- mbrx-20251030.xsd (EX-101.SCH) — 3KB
- mbrx-20251030_def.xml (EX-101.DEF) — 11KB
- mbrx-20251030_lab.xml (EX-101.LAB) — 15KB
- mbrx-20251030_pre.xml (EX-101.PRE) — 11KB
- mbrx20251030_8k_htm.xml (XML) — 3KB
01
Item 7.01 Regulation FD Disclosure On October 30, 2025, Moleculin Biotech, Inc. (the "Company") is using the attached presentation for its corporate presentation posted on the Company's website and is set forth as Exhibit 99.1 herein. The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be "filed" for the purpose of the Securities Exchange Act of 1934, as amended ("Exchange Act"), nor shall it be incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended ("Securities Act"), unless specifically identified therein as being incorporated by reference.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Investor Presentation dated October 2025 104 Cover page Interactive Data File (formatted as Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MOLECULIN BIOTECH, INC. Date: October 30, 2025 By: /s/ Jonathan P. Foster Jonathan P. Foster